Ranked #1,252 of 8,699 institutional investors
General Atlantic, L.P.
New York, NY
$2.69B
US stock portfolio at live prices · today −$43.7M (−1.60%)
Market closed. Prices as of Nov 20, 8:41 AM ET
- Value at quarter end (Q3 2026)
- $2.48B
- Change from Q2 2026
- −$426.3M (−14.66%)
- Positions
- 8 · 1 new, 1 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$1.02B of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesLFTO 22.2%CHYM 21.7%ALKT 9.09%SPTX 4.15%KRSA 1.80%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| LFTO Liftoff Mobile, Inc. | 25,315,646 | $599M | 22.2% | Unchanged |
| CHYM Chime Financial, Inc. | 18,926,627 | $584M | 21.7% | Reduced −11% |
| ALKT Alkami Technology, Inc. | 19,379,038 | $245M | 9.09% | Unchanged |
| SPTX Seaport Therapeutics, Inc. | 6,101,582 | $112M | 4.15% | Unchanged |
| KRSA Korsana Biosciences, Inc. | 1,366,242 | $48.4M | 1.80% | New |
| PBLS Parabilis Medicines, Inc. | 1,538,461 | $42.5M | 1.58% | Unchanged |
| NRIX Nurix Therapeutics, Inc. | 3,032,185 | $41.2M | 1.53% | Unchanged |
| GROV Grove Collaborative Holdings, Inc. | 2,474,859 | $2.1M | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| RVMD Revolution Medicines, Inc. | 357,791 | $57.0M |